statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What Happened With Conduit Pharmaceuticals (CDT) Stock Today?

Conduit Pharmaceuticals shares traded higher by over 50% early Tuesday. The company announced it received patent approval for its lead asset targeting autoimmune diseases.
read more...

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Conduit also appoints prominent intellectual property attorney Jeffrey Lindeman as a Consultant Leadership additions underscore Conduit's commitment to strengthening and broadening its intellectual...

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Short Interest Down 39.1% in February

Conduit Pharmaceuticals Inc. (NASDAQ:CDT  Get Free Report) was the recipient of a large decline in short interest in the month of February. As of February 29th, there was short interest...

Conduit Pharmaceuticals opens laboratory space in Cambrige, UK

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory...

Private equity firms among Conduit Pharmaceuticals Inc.'s (NASDAQ:CDT) largest shareholders, saw gain in holdings value after stock jumped 18% last week

Key Insights Significant control over Conduit Pharmaceuticals by private equity firms implies that the general public...

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

SAN DIEGO and LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit"), a multi-asset, clinical-stage life science company delivering an efficient model for...

Conduit Pharmaceuticals (NASDAQ:CDT) Shares Up 4.7%

Conduit Pharmaceuticals Inc. (NASDAQ:CDT  Get Free Report)s share price shot up 4.7% during mid-day trading on Thursday . The company traded as high as $5.15 and last traded at $4.89...

Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships. Its medical needs in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in San Diego, CA.

Volume	1.31M
52-Wk High	$12.89
52-Wk Low	$0.211

CDT Conduit Pharmaceuticals Inc

About

Feed

News

Sentiment

Fundamentals